Using social media doesn't have to mean posting goofy cat videos or sharing pictures of every meal you are about to eat. It actually can play a meaningful role in enhancing your intellectual property practice and taking relationships with clients to a new level. Here, IP attorneys give four reasons why they are using social media.
Scan Top Enterprise Co. has reached a preliminary settlement with a rival wiper blade manufacturer that allegedly infringed on certain of its patents, and the companies urged an Illinois federal court Thursday to stay the suit while they finalize the deal.
Mylan and Ranbaxy said Thursday that purchasers bringing pay-for-delay claims over the narcolepsy drug Provigil have failed to give the Third Circuit any good reason to uphold a class certification order, which the drugmakers have attacked as unsupported by the buyers’ damages theory.
Shiboleth LLP on Thursday was smacked with a $10 million malpractice suit in New York federal court by a maker of toddler products claiming that the firm exaggerated its litigation experience, which led to its poor handling of an underlying patent infringement suit against Walgreen Co. and a subpar settlement.
Rovi Solutions Corp., which provides digital media guides and licenses entertainment device patents, said Friday it is acquiring set-top-box maker TiVo Inc. in a $1.1 billion cash and stock deal guided by Cooley LLP and Skadden Arps Slate Meagher & Flom LLP.
The Federal Circuit on Friday denied liquid sweetener company TC Heartland LLC’s request for new restrictions on where patent suits can be filed, rejecting an argument that would have effectively barred most suits from the patent hotbed of the Eastern District of Texas.
A Delaware vice chancellor signaled plans Thursday for a deep post-trial dive into a dispute over a once-jailed former Goldman Sachs vice president’s demand for corporate officer indemnification and legal fees, with responsibility for millions in Goldman legal bills in the balance.
The Eleventh Circuit on Thursday refused to block Gap Inc. from selling Old Navy shirts with the phrase “Eat Sleep Ball,” denying a request by a clothing and accessories brand accusing Gap of infringing and counterfeiting its trademark.
Google lost a handful of pretrial challenges to an infringement suit alleging the Silicon Valley heavyweight stepped on a German architectural firm’s patent related to a virtual Earth map when a Delaware federal judge on Thursday refused to find the patent invalid or ineligible.
UMG Recordings and in-flight entertainment provider Global Eagle Entertainment convinced a California federal judge Wednesday to delay by several months an impending May trial on Global Eagle's damages for willfully infringing 4,500 UMG-owned songs, saying they were heading to mediation in June.
Oracle and Google on Wednesday both told the California federal judge overseeing the looming $8 billion copyright trial over Google's use of Oracle software code in its Android operating system that they're still not happy with his proposed jury instructions.
The Federal Circuit's holding that America Invents Act decisions must be reviewed with deference on appeal could inspire the U.S. Supreme Court to consider requiring greater scrutiny of the Patent Trial and Appeal Board, which could make AIA decisions easier to overturn, attorneys say.
The operator of several Church’s Chicken franchises in Texas has been accused of using the fast food chain’s trademarks after defaulting on licensing agreements in violation of unfair competition and trademark laws, according to a suit filed in Georgia federal court.
Eastern District of Texas Judge Rodney Gilstrap has invalidated two patents on "digital labeling" of websites, finding that they claim only an abstract idea under the U.S. Supreme Court's Alice standard, and knocking out a recent jury verdict that New Life Ventures Inc. infringes.
A small Florida coffee company is fighting back against legal threats made by Monster Energy Co. over a coffee blend named for the lead singer of the rock group the B-52s, blasting the drink maker for using “dubious” trademark claims to establish an "anti-competitive monopoly" on the word “monster.”
InterDigital urged a Delaware federal court on Wednesday to allow the company to ask the Federal Circuit whether it should face allegations that it violated federal antitrust law after Microsoft failed to identify the specific patents that InterDigital allegedly relies upon to set what Microsoft calls unfair terms for licensing wireless technology.
Steve Madden Ltd. told a New York federal judge on Thursday that it reached a settlement with fashion designer Stella McCartney Ltd. to end a suit accusing the apparel retailer of infringing both design patents and trade dress by selling a knockoff shoulder bag.
A copyright lawsuit over a "Star Trek" fan film has caught the attention of a constructed languages group, which argued Wednesday that Paramount Pictures can’t copyright Klingon — and it did so in a brief written partially in the fictional language.
A Florida federal court Thursday denied an information technology consultant's request for a new trial after a jury found it misappropriated a security access IT system from a U.S. Navy contractor, but reduced the $5 million award by $250,000 because of juror error.
The U.S. Food and Drug Administration is flouting a recent court ruling and federal law by refusing to grant orphan drug exclusivity for chemotherapy infusion Bendeka, according to a complaint filed Wednesday in D.C. federal court.
Merck on Wednesday escalated a war of words with Gilead over accusations that a Merck attorney lied during a deposition over accessing confidential information, saying its biopharmaceutical rival wants to “exploit” the allegation as a “get-out-of-jail-free card” after a California’s federal jury’s recent $200 million damages award in the patent infringement case.
As Saudi Arabia's market continues to expand and with its stock market becoming increasingly opening to foreign investors, many U.S. companies and banks are expanding operations in and to the kingdom. These expansions pose a great opportunity for many technology and life science companies — and the potential for the theft or misappropriation of a company’s trade secrets by an employee or business partner, say Paul Keller and Jihad ... (continued)
The Federal Trade Commission's recent complaint against Endo Pharmaceuticals — the FTC's first lawsuit challenging a "no-authorized-generic" agreement — reflects a number of positions that the FTC has taken in litigation or in amicus briefs, but more broadly reflects two characteristics of commission legal actions against Hatch-Waxman settlements, say Robert Reznick and David Goldstein of Orrick Herrington & Sutcliffe LLP.
In addition to providing a forum for centralized enforcement of European patents, the Unified Patent Court will offer a new opportunity for challengers to invalidate a European patent centrally in a single action. There are some similarities between UPC revocation actions and the hugely successful inter partes reviews in the U.S., say Leythem Wall and Hazel Ford of Finnegan Henderson Farabow Garrett & Dunner LLP.
The Federal Circuit's recent decision in Shaw Industries Group v. Automated Creel Systems as to the scope of the estoppel provided in 35 U.S.C § 315(e) appears to be contrary to the scope that practitioners and the legislators had in mind when the America Invents Act was passed, say Cyrus Morton and Ryan Schultz of Robins Kaplan LLP.
The U.S. Food and Drug Administration's recently updated expedited review of abbreviated new drug applications for “sole-source” drug products is a positive development that will provide incentives for generic companies to develop generic versions of off-patent one-source drugs, with potential benefits of keeping the cost of generic drugs down and reducing drug shortage, say Jason Luo and Jordana Garellek at Duane Morris LLP.
While PACER is a powerful tool for gaining information, practitioners should keep in mind that certain flaws often cause lawyers to be omitted from cases they’ve worked on or to show up associated with the wrong firm. These errors build up across aggregate records, tainting any conclusions drawn from such data — often to a surprising extent, according to Brian Howard, a legal data scientist at Lex Machina.
On April 25, the U.S. Supreme Court once again will hear argument in Kirtsaeng v. Wiley and visit — for the first time in at least 20 years — the issue of attorneys' fee awards in copyright cases. While Wiley argues that the circuit split is exaggerated and the district court did not abuse its broad discretion in applying the nonexclusive factors to its analysis under the Copyright Act, what we are witnessing is the continued erosi... (continued)
Next week, the U.S. Supreme Court will hear oral arguments in Cuozzo and review the use of the broadest reasonable interpretation standard for claim construction in inter partes review. The Federal Circuit's recent decision in PPC v. Corning provides a clear demonstration of how selecting the right claim construction standard can be “outcome determinative,” say Lucas Tomsich and Richard Marsh of Faegre Baker Daniels LLP.
Rather than giving the "monkey selfie" case the careful consideration that it deserves, a recent Law360 Expert Analysis article opted for dismissive retorts. PETA's argument in a federal court on behalf of a monkey named Naruto made legal history, and we have the moral imperative to further the evolution of the law, which has proved so vital to the betterment of our society in the past, says Jeffrey Kerr, general counsel at PETA.
As the launch of biosimilars in the U.S. picks up momentum, so too will the number of high-stakes biologic-biosimilar disputes. However, the traditional economic analysis employed for Hatch-Waxman brand-generic disputes, while still useful, will not be sufficient to guide irreparable harm and other economic analysis in this new life sciences competitive landscape, says Michal Malkiewicz, a director at Epsilon Economics LLC.